Kenneth Bahrt, SVP, Chief Medical Officer at SAVIENT PHARMACEUTICALS INC (SVNT), sold 1,300 shares at $1.03 ($1K) on 2013-01-31, disclosed to the SEC on 2013-02-04.
Scheduled sale ($1k) by SVP, Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SVNT | SELL | 2013-10-17 | $6K | — | Filing → |
| SVNT | SELL | 2013-05-01 | $925 | — | Filing → |
| SVNT | SELL | 2013-02-06 | $30K | — | Filing → |